Babcock LW, Knoblauch M, Clarke MS. The role of myostatin and activin receptor IIB in the regulation of unloading-induced myofiber typespecific skeletal muscle atrophy. J Appl Physiol 119: 633-642, 2015. First published July 23, 2015 doi:10.1152/japplphysiol.00762.2014.-Chronic unloading induces decrements in muscle size and strength. This adaptation is governed by a number of molecular factors including myostatin, a potent negative regulator of muscle mass. Myostatin must first be secreted into the circulation and then bind to the membrane-bound activin receptor IIB (actRIIB) to exert its atrophic action. Therefore, we hypothesized that myofiber type-specific atrophy observed after hindlimb suspension (HLS) would be related to myofiber type-specific expression of myostatin and/or actRIIB. Wistar rats underwent HLS for 10 days, after which the tibialis anterior was harvested for frozen cross sectioning. Simultaneous multichannel immunofluorescent staining combined with differential interference contrast imaging was employed to analyze myofiber type-specific expression of myostatin and actRIIB and myofiber type cross-sectional area (CSA) across fiber types, myonuclei, and satellite cells. Hindlimb suspension (HLS) induced significant myofiber type-specific atrophy in myosin heavy chain (MHC) IIx (P Ͻ 0.05) and MHC IIb myofibers (P Ͻ 0.05). Myostatin staining associated with myonuclei was less in HLS rats compared with controls, while satellite cell staining for myostatin remained unchanged. In contrast, the total number myonuclei and satellite cells per myofiber was reduced in HLS compared with ambulatory control rats (P Ͻ 0.01). Sarcoplasmic actRIIB staining differed between myofiber types (I Ͻ IIa Ͻ IIx Ͻ IIb) independent of loading conditions. Myofiber types exhibiting the greatest cytoplasmic staining of actRIIB corresponded to those exhibiting the greatest degree of atrophy following HLS. Our data suggest that differential expression of actRIIB may be responsible for myostatin-induced myofiber type-selective atrophy observed during chronic unloading. chronic unloading; atrophy; myostatin; activin receptor IIB; fiber type SKELETAL MUSCLE IS RESPONSIVE to varying levels of chronic mechanical loading, undergoing hypertrophy in response to increased loading and atrophy following chronic unloading. At a fundamental level, mechanical load directly impacts the expression of myofibrillar proteins responsible for the contractile properties of individual myofiber types, which are categorized (in rats) as fiber types I, IIa, IIx, and IIb in order of increasing cross-sectional area (CSA) and anaerobic properties (5, 45). These myofiber types can be identified by immunofluorescent detection of myosin heavy chain (MHC) protein isoforms I, IIa, IIx, and IIb as well as by histochemical methods, which rely on the enzymatic properties of myosin ATPase across the various myofiber subtypes (5, 35). These various myofiber types not only differ in CSA and contractile properties in normal, healthy muscle but also hypertrophy and atrophy at different rates in response to a variety of stimuli, including mechanical loading conditions (4, 15, 17, 20, 28, 46, 48, 49) .
SKELETAL MUSCLE IS RESPONSIVE to varying levels of chronic mechanical loading, undergoing hypertrophy in response to increased loading and atrophy following chronic unloading. At a fundamental level, mechanical load directly impacts the expression of myofibrillar proteins responsible for the contractile properties of individual myofiber types, which are categorized (in rats) as fiber types I, IIa, IIx, and IIb in order of increasing cross-sectional area (CSA) and anaerobic properties (5, 45) . These myofiber types can be identified by immunofluorescent detection of myosin heavy chain (MHC) protein isoforms I, IIa, IIx, and IIb as well as by histochemical methods, which rely on the enzymatic properties of myosin ATPase across the various myofiber subtypes (5, 35) . These various myofiber types not only differ in CSA and contractile properties in normal, healthy muscle but also hypertrophy and atrophy at different rates in response to a variety of stimuli, including mechanical loading conditions (4, 15, 17, 20, 28, 46, 48, 49) .
Individual myofiber CSA is dependent on net myofibrillar protein balance, which in turn is dictated by the activity of a variety of molecular signaling pathways related to the magnitude of mechanical loading. Insulin-like growth factor-1 (IGF-1) has been shown to play a major role as a potent stimulator of hypertrophic gene transcription and translation, in turn inducing a net positive protein balance through activation of the Akt/mTOR pathway (6, 34, 38, 43) . Myostatin, a negative regulator of muscle mass and satellite/progenitor cell differentiation, has been shown to inhibit Akt/mTOR activation, initiating the atrophic, myosin-specific E3-ligase ubiquitin proteosome pathway (29, 30, 32, 33, 39) . Myostatin also activates myogenic inhibitory transcription factors Smad2 and Smad3 (40) , ultimately resulting in a negative myofiber protein balance and subsequent myofiber atrophy.
Considering the potency of myostatin as an atrophic factor, it is likely involved in myofiber type-specific atrophy following chronic unloading. However, myostatin exerts its function through paracrine-mediated pathways; it is secreted into the circulation before activating its target receptor. Myostatin and its propeptide are secreted into the circulation by both skeletal muscle tissue and adipose tissue where it exists in the circulation as a complex along with the myostatin propeptide and follistatin or follistatin-like protein (16, 56) . Myostatin can only exert its atrophic effects in skeletal muscle once it disassociates from this complex and binds to the activin receptor IIB (actRIIB) located on the myofiber sarcolemma (23) . As such, myofiber type-specific actRIIB expression as well as myofiber type-specific myostatin expression may be equally important in modulating myofiber atrophy during unloading.
Traditionally, whole muscle lysates have been used to investigate intramuscular signaling events such as myostatin expression in response to exercise and chronic unloading. This method, however, cannot resolve differences in these signaling events between myofiber types and cannot be used to investigate the role of such signaling events in myofiber type-specific adaptations such as mechanically load-induced myofiber atrophy (50) . To investigate the possibility that myofiber typespecific atrophy responses observed in unloaded muscle may involve simultaneous alterations in both myostatin and actRIIB expression, we have employed a multiplex immunofluorescent staining technique that allows simultaneous identification of the multiple fiber types found in rodent muscle along with expression of either myostatin or the actRIIB receptor by these individual myofiber types. Considering that myostatin can only activate its subsequent intracellular atrophic pathway via the sarcolemma actRIIB receptor, this study sets out to test the hypothesis that either myostatin and/or actRIIB will be ex-pressed in greater amounts by those myofiber types undergoing the greatest amount of atrophy in response to unloading.
METHODS
Hindlimb suspension. Following University of Houston Institutional Review Board approval, 6-mo-old male Wistar Rats were divided into either ambulatory control (AMBU; n ϭ 6) or hindlimb suspension (HLS; n ϭ 6) groups. All rats were housed individually, subjected to a 12:12-h light-dark cycle, and had access to water and standard laboratory rodent chow ad libitum. Rats were subjected to 10 days of hindlimb suspension (HLS) while cage-matched controls (AMBU) were allowed to move freely about the cage. After the hindlimb suspension procedure was complete, animals were anesthetized followed by harvesting of the red tibialis anterior (Red TA) muscle for cross sectioning. This particular muscle was chosen for its rich fiber type distribution (described in Fig. 1 ), as this investigation is in regards to fiber type-specific differences. A detailed description of the animal care, hindlimb suspension, and tissue collection protocols is published elsewhere (28) . In some cases, due to limited numbers of muscle sections being available from each animal/muscle, the number of animals per experimental group in specific data sets ranged from six to four animals depending on the analysis.
Metachromatic ATPase. The metachromatic ATPase method allows for simultaneous fiber-type identification based on physiological function (i.e., MHC ATPase activity) rather than MHC-isoform protein expression (35) . With the use of a modified version of the metachromatic ATPase staining protocol (28) , frozen cross sections were first incubated in a preincubation medium containing 50 mM potassium acetate and 23 mM calcium chloride at pH 4.35 for 2 min followed 3 ϫ 2 min washes in Tris buffer (pH 7.8). Samples were then incubated for 25 min in a solution adjusted to pH 9.4 containing 50 mM potassium chloride, 2.75 mM ATP disodium salt, 18 mM anhydrous CaCl, and 6.7% (vol/vol) Sigma221 buffer. This was followed by 4 ϫ 2 s dips in a 90-mM solution of CaCl 2, repeated three times using fresh CaCl2 solution each time. Samples were then incubated in a solution of 0.1% (wt/vol) toluene blue for 90 s, followed by a 30-s rinse in deionized water, 5 ϫ 2-s dips in 95% ethanol, 5 dips in 100% ethanol, and finally placed in Xylene until ready to mount. Slides were mounted with Permount mounting medium and sealed with clear nail polish. Myofiber types were labeled as illustrated in Fig. 2 .
Immunofluorescent staining. Multichannel immunofluorescent staining (IF) was employed for analysis of myofiber CSA based on differential MHC protein expression, as well as histological and quantitative analysis of active/mature myostatin (COOH terminus) and actRIIB receptor protein expression and tissue localization using a modified version of the protocol previously described (11) . Antibody cocktails used to identify the various MHC isoforms along with myostatin or actRIIB proteins are shown in Table 1 . Frozen cross sections to be stained for actRIIB receptor were first fixed in Dulbecco's (D)-PBS buffer (pH 7.2) containing 0.5% (vol/vol) freshly generated formaldehyde for 2 min, followed by washing in three changes of fresh D-PBS buffer (pH 7.2) over a period of 10 min. Sections to be stained for myostatin remained unfixed and were rehydrated in three changes of D-PBS buffer (pH 7.2) over a period of 10 min. All sections were then incubated in D-PBS buffer (pH 7.2) containing 50 mM ammonium chloride solution for 30 min to reduce endogenous autofluorescence, followed by two washes in fresh D-PBS buffer (pH 7.2) for 5 min. Sections were permeabilized by incubation in D-PBS buffer (pH 7.2) containing 0.1% (vol/vol) Triton X-100 for 5 min followed by two washes in D-PBS for 5 min. Sections were then incubated in D-PBS buffer (pH 7.2) containing 4% (vol/vol) heat-inactivated normal goat serum (HIGS) for 30 min to block nonspecific protein binding and rinsed once with D-PBS buffer (pH 7.2) before application of primary antibody mixtures.
All primary and secondary antibody cocktails were prepared at the working concentrations listed in Table 1 by diluting in D-PBS buffer (pH 7.2) containing 1% HIGS followed by centrifugation at 10,000 rpm for 5 min immediately before use. Sections were incubated with primary antibody cocktail solution overnight at 4°C, after which time they were washed in fresh D-PBS buffer (pH 7.2) a total of five times over 30 min. After being washed, sections were incubated for 1 h with the appropriate secondary antibody cocktail. Sections were then washed five times in D-PBS over 30 min, mounted with a coverslip using Fluormount G anti-fading agent (cat. no. 100-01; Southern Fig. 1 . Graphical representation of 5 discrete regions identified in the rat tibialis anterior (TA) muscle, which exhibit spatially distinct populations of various myofiber types (13) . To ensure our analyses included all 4 myofiber types found in rat muscle, this study utilized images from regions 4 and 5, also known as the Red TA. Biotechnology Associates), and sealed with clear nail polish to prevent dehydration. All samples were stored in the dark at 4°C until imaged.
To ensure the various combinations of antibodies produced images that accurately represented multiple protein expression levels, samples were first prepared using the protocol described above with and without primary antibodies (experimental vs. secondary-only controls, respectively). Secondary-only control samples were imaged by confocal microscopy using an Olympus FV1000 confocal microscope and imaging software (Olympus FV10-ASW version 3.1, Center Valley, PA) to determine the confocal imaging conditions where no significant nonspecific, secondary antibody-only binding was observed. Secondary control images collected under these imaging conditions appeared completely black. Next, experimental samples were imaged under identical imaging parameters to determine primary antibody binding and to allow comparison of protein expression levels between control and HLS conditions, as well as between different myofiber types. With the use of multiple primary and secondary antibodies in a single cocktail, it was necessary to ensure there was no nonspecific crossover binding between primary and secondary antibodies. This was achieved by comparing images incubated with either a single primary antibody disclosed using a mixture of multiple secondary antibodies or vice versa. Any differences between these images compared with images using a single primary and its respective secondary antibody would indicate nonspecific binding interactions between the multiple immunoglobulins present in the antibody "cocktail." No such nonspecific interactions were observed with the specific antibody cocktails utilized in this study.
Confocal microscopy. Immunofluorescently stained frozen cross sections of rat TA muscle were imaged using an Olympus FV1000 confocal microscope and imaging software (Olympus FV10-ASW version 3.1). Imaging parameters were selected based on secondary antibody-only control samples to ensure image-capture parameters were set to exclude fluorescent signal associated with tissue autofluorescence and any nonspecific secondary antibody binding. Before all experimental samples were imaged, secondary controls in the same sample set were viewed first to ensure consistency in staining within and between animals. This ensured that images from different animals/experimental groups (i.e., control and HLS) could be collected under the same imaging conditions to allow appropriate comparison.
The TA muscle has varying myofiber CSA and myofiber type distribution between different regions as displayed in Fig. 1 . Because the focus of this investigation was to determine potential fiber type differences, the region of the TA containing the greatest variability in myofiber types were chosen for subsequent analysis. These regions are noted as regions "4" and "5" in Fig. 1 (13) , also referred to as the red tibialis anterior (Red TA) (5). Images used for subsequent myofiber type CSA analysis were captured at ϫ20 magnification. Eight images were collected per cross section to ensure the majority of the Red TA was included in the analysis. Myofibers were included in the analysis if each myofiber cross section was complete and exhibited no visible physical damage or processing artifacts. With the use of the antibody cocktails described above, all four fiber types found in rodent muscle can be identified based on their selective expression of specific MHC protein isoforms. Type I (i.e., MHC-I isoform expression), type IIa (i.e., MHC-IIa isoform expression), and type IIb (i.e., MHC-IIb isoform expression) myofibers were simultaneously identified in muscle sections by immunofluorescent staining using a cocktail of all three MHC isoform antibodies (Fig. 2) . Those myofibers negative for MHC-I, IIa, and IIb isoforms were classified as MHC-IIx myofibers by a process of elimination.
Initial data from sections stained for myostatin indicated that myostatin protein were localized to myonuclei and satellite cells, rather than the myofiber sarcoplasm. Since the inclusion of a fluorescent nuclear stain (i.e., DAPI) to positively identify myonuclei and satellite cells was impossible when combined with identification of MHC-I myofibers (i.e., since a DyLight 405-nm labeled secondary antibody was used to disclose the MHC-I primary antibody), it was necessary to first demonstrate that myostatin protein localization coincided with nuclear staining (i.e., DAPI staining) in a separate analysis, as shown in Fig. 3 . This analysis revealed all myonuclei and satellite cells present in cross sections of the Red TA to contain myostatin as detected using IF staining, with myostatin staining being Antibody combinations for myosin heavy chain (MHC) I (BA-F8), MHC IIa (SC-71), and MHC IIb (BF-F3) (Developmental Studies Hybridoma Bank, Department of Biology, University of Iowa) were used to identify their corresponding myofiber type in all samples used for cross-sectional area, myostatin, and activin receptor IIB (actRIIB) staining intensity measurements. Primary antibodies for myostatin (Bethyl cat no. A300-401A) and actRIIB (Abbiotec cat no. 251300) were used to stain separate samples due to the use of the same secondary antibody. Antibody isoforms were chosen based on the range of detectable fluorescent light on the microscope and lack of overlap in excitation wavelengths. Working concentrations of all antibodies were determined experimentally. absent throughout the rest of the cross section. Therefore, in subsequent analyses utilizing multiple primary antibodies for MHC isoforms, positive myostatin staining served as histochemical identification of myonuclei and satellite cells.
The histological criteria for differentiating between satellite cells and myofiber nuclei are that myonuclei are found adjacent but inside the sarcolemma of the myofiber, whereas satellite cells are found adjacent but outside the sarcolemma of the myofiber (21) . The histological location of myonuclei and satellite cells was determined by the use of differential interference contrast (DIC) imaging, as illustrated in Fig. 4 . Proceeding histological identification of nuclei or satellite cells, myofiber type was determined based on MHC isoform expression. Interstitial nuclei, which are located outside cell membranes, classified as not being adjacent to or associated with any particular myofiber were not included in the analysis.
All images at each magnification were taken under identical imaging conditions to allow relative comparison of staining intensity between fiber types and loading conditions. Images to be used for myostatin and actRIIB quantification were captured at ϫ60 magnification in combination with a DIC image of the identical region of the section for histological identification of cell membranes, cytoplasm, nuclei, and satellite cells, as demonstrated in Figs. 5 and 6.
Image analysis. All image analyses were performed using Photoshop CS6 (Adobe Systems, San Jose, CA). Images stained using IF and captured using confocal microscopy were opened in Photoshop as digital layers, with each channel from the microscope a different layer. Fiber type was identified based on fluorescent staining color (or absence of staining for type IIb myofibers), while the magnetic lasso tool was used to encircle individual myofibers, myonuclei, and/or satellite cells. Myofiber CSA, myonuclear area, and satellite cell area was calculated by conversion of pixel count to square microns based on calibration of the imaging software using the scale bar appearing on the original confocal image. An Integrated Density (ID) value for each outlined structure was calculated (i.e., total pixel intensity). In addition to the ID value, a Grey Scale Intensity (GSI) value was calculated for each outlined structure (i.e., pixel staining intensity/ total area). In this way, two separate staining parameters could be assessed for each outlined structure, namely ID (a measure of total staining signal independent of area) and GSI (a staining intensity measure normalized to area). For nuclei and satellite cell GSI measurements of myostatin staining, DIC images were used to differentiate between nuclei and satellite cells (Fig. 4) . Although actRIIB staining was also present in nuclei and satellite cells, differentiating these regions from membrane staining was impossible to perform accurately. Therefore, only membrane, cytoplasmic, and total fiber staining measurements were taken for actRIIB, with myonuclear and satellite cell staining including in membrane staining measurements. Sections stained using the metachromatic ATPase stain were analyzed for CSA by encircling the myofiber borders after each fiber type was identified based on color.
Statistical analysis. A two-way ANOVA was used to analyze myofiber atrophy from images stained using both the metachromatic ATPase stain and MHC isoform-specific IF staining. For analysis of individual myofiber type-specific atrophy, ANOVAs were performed for each myofiber type. Two-way ANOVAs were also used to analyze myofiber type myostatin staining in both myonuclei and/or satellite cells between AMBU and HLS conditions. The same statistical procedure was applied to myofiber type-specific myonuclei (MN) and satellite cell (SC) content (MN and SC per myofiber) and membrane, cytoplasmic, and total myofiber staining of actRIIB between loading conditions. To determine overall fiber type-specific differences in myostatin and actRIIB staining independent of conditions, a four-way repeated-measures ANOVA was applied for each variable previously described, where each fiber type served as the within-subject factors. Bonferonni adjustments were applied to post hoc analyses as needed. Statistical significance was set at P Ͻ 0.05.
RESULTS

Identifying myofiber types via metachromatic ATPase and immunofluorescent MHC isoform staining. Metachromatic
ATPase staining in the TA allowed discrimination of three myofiber types based on color (type I: dark blue; type IIa: pale blue; and type IIb: medium blue) whereas simultaneous multichannel IF staining of MHC protein isoforms (MHC I, MHC IIa, and MHC IIb) allowed discrimination of myofiber types (type I: blue; type IIa: purple; type IIx: no staining/ black; and type IIb: red) present in the Red TA. Comparing the two methodologies, identification of myofiber type using multiplex MHC isoform IF is in this case superior to the metachromatic ATPase approach in that it is able to discriminate all four myofiber types present in rat TA muscle while also allowing investigation of myostatin or actRIIB expression in the same section. Representative images of both techniques are displayed in Fig. 2 .
Myofiber-specific atrophy in the red TA using immunofluorescent MHC isoform staining. An initial two ϫ four-way ANOVA revealed that loading conditions had a significant effect on CSA (P Ͻ 0.01; n ϭ 5; 707 Ϯ 215 fibers per animal) and that there was a condition ϫ myofiber type interaction. Further two-way ANOVAs indicated a difference in myofiber CSA between conditions in MHC-IIx and IIb myofibers (P ϭ 0.048 and P ϭ 0.03, respectively) but no difference in MHC-I or MHC-IIa myofibers. These data, displayed in Fig. 7 , indicate that the rat Red TA undergoes MHC-IIx-and MHC-IIb-selective myofiber atrophy during chronic unloading, with MHC IIb myofibers undergoing the greatest amount of atrophy.
Myofiber type-specific atrophy of the red TA via metachromatic ATPase staining. An initial ANOVA revealed a significant difference between fiber type CSA independent of condition (P Ͻ 0.01; n ϭ 4; 598 Ϯ 70 fibers per animal), with a significant difference between conditions seen in type IIb fibers only (P Ͻ 0.05). Results are displayed in Fig. 7 .
Myofiber type-specific myonuclei and satellite cells in AMBU and HLS rats. Myonuclei and satellite cells per myofiber were assessed by identifying and distinguishing between myonuclei and satellite cells as demonstrated in Fig. 4 . An initial two-way ANOVA found myonuclei per myofiber to be less in HLS rats compared with AMBU controls (P Ͻ 0.01) Fig. 7 . Morphometric image analysis demonstrating myofiber type-specific atrophy in the Red TA muscle of rat after 10 days of HLS. Myofiber cross-sectional area (CSA) was assessed using sections stained for metachromatic ATPase (A) or MHC isoform staining (B) followed by morphometric analysis (28) . Significant (*P Ͻ 0.05) atrophy of type IIb myofibers was observed in sections stained using the metachromatic ATPase stain (A). Significant (*P Ͻ 0.05) atrophy was observed in both type IIb and type IIx myofiber types when multichannel IF staining of MHC isoforms was used to discriminate all 4 myofiber types present in the TA muscle (B). and illustrated an overall myofiber type-specific effect (P Ͻ 0.01; n ϭ 5; 107 Ϯ 20 myofibers per animal). Post hoc analysis revealed myonuclei per myofiber to be greater in MHC IIb myofibers compared with MHC I (P Ͻ 0.01), MHC IIa (P Ͻ 0.01), and MHC IIx (P Ͻ 0.01) myofibers. Independent t-tests between conditions for each myofiber type revealed a difference between conditions for MHC IIx fibers only (P Ͻ 0.01). These data are displayed in Fig. 8A .
Satellite cells per myofiber were found to be less in HLS rats compared with AMBU controls with no differences between myofiber types (P Ͻ 0.01). Independent t-tests between conditions for each myofiber type revealed differences between conditions for MHC IIx (P Ͻ 0.05) and MHC IIb (P Ͻ 0.05) myofibers. These data are displayed in Fig. 8B .
Myofiber type-specific myostatin staining in AMBU and HLS rats. Myostatin staining was found localized to myonuclei, interstitial nuclei, and satellite cells. When myonuclei and satellite cells were analyzed separately, myostatin staining in myonuclei was greater in AMBU control rats compared with HLS rats (P Ͻ 0.05; n ϭ 5;160 Ϯ 24 myonuclei/43 Ϯ 11 satellite cells per animal), but satellite cell staining remained unchanged between conditions. Results are displayed in Fig. 9A .
Myofiber type-specific ActRIIB staining in AMBU and HLS rats. No statistically significant differences in total, membrane, or cytoplasmic actRIIB staining were found between conditions with an initial two-way ANOVA (n ϭ 6; 122 Ϯ 35 fibers per animal). However, a four-way repeated measures ANOVA revealed significant differences in cytoplasmic staining between fiber types independent of loading conditions, where type I fibers were different from type IIa, type IIx, and type IIb (P Ͻ 0.05, P Ͻ 0.01, and P Ͻ 0.01, respectively); type IIa fibers were different from type IIx and type IIb (P Ͻ 0.01, P Ͻ 0.05, respectively); while no difference was found between type IIx and type IIb fibers. A linear polynomial contrast plot revealed a significant trend in cytoplasmic staining in the following fashion: I Ͻ IIa Ͻ IIx Ͻ IIb (P Ͻ 0.01). ActRIIB staining was also observed in nuclei, satellite cells, interstitial nuclei, and cell membranes. Results are displayed in Fig. 9B .
Interstitial nuclei. Given this investigation was in regards to fiber-type-specific differences, interstitial nuclei were not analyzed for staining intensity, as they were not associated with any particular myofiber type. However, it is particularly interesting that both myostatin and actRIIB are prominently expressed in this cell type. It is notable that actRIIB demonstrated prominent staining in some interstitial cells, and minimal-to-no staining in others while myostatin staining was seen in all interstitial nuclei. Examples of interstitial cell staining can be seen in Fig. 10 .
DISCUSSION
Myofiber type-selective atrophy in rat TA. Our results demonstrate a fiber type-selective atrophic response in the rat Red TA following HLS, which corresponds to differential cytoplasmic staining for actRIIB, independent of loading condition. Myofiber CSA measurements of the Red TA from the control AMBU group as measured via IF are in agreement with measurements from others (5) . HLS data for the TA is lacking, and we may be the first to demonstrate an unloading-induced fiber type-specific atrophic response in this particular muscle. The myofiber-selective atrophic response seen in the Red TA is typical of most muscles undergoing unloading-induced atrophy, with the exception of the soleus (28) . With the present data, differences between IF and metachromatic ATPase methods of identifying myofiber types may be attributed to the lack of differentiation between type IIx and IIb fibers via metachromatic ATPase staining, where type IIx myofibers may be mistakenly identified as either type IIa or IIb when employing the metachromatic ATPase method. While the metachromatic ATPase method does not require the use of expensive antibodies and a fluorescent microscope, based on our data multiplex MHC isoform IF offers a more complete method of myofiber type discrimination, identification, and assessment of myofiber type-specific CSA and myofiber type-specific protein expression.
Spatially resolving myostatin expression. Most current methods of quantifying protein expression in skeletal muscle use analysis of whole muscle lysates and therefore do not allow the assessment of myofiber type-specific expression of proteins unless more complex techniques are employed such as spatially resolved molecular pathology utilizing laser capture mi- Fig. 8 . Quantitative analysis of myonuclei per myofiber (A) and satellite cells per myofiber (B) of the rat Red TA from AMBU and HLS rats. (*P Ͻ 0.05, **P Ͻ 0.01) An initial two-way ANOVA of myonuclei per myofiber revealed differences in between loading conditions (P Ͻ 0.01) and myofiber type (P Ͻ 0.01). Post hoc analysis of myofiber type-specific myonuclei per myofiber found MHC IIb myofibers to have greater numbers of myonuclei compared with MHC I (P Ͻ 0.01), MHC IIa (P Ͻ 0.01), and MHC IIx (P Ͻ 0.01). Independent t-tests between conditions for each myofiber type revealed a decrease in myonuclei per myofiber in MHC IIx myofibers only (P Ͻ 0.01; A). An initial two-way ANOVA of satellite cells per myofiber revealed a difference between loading conditions. Independent t-tests between conditions for each myofiber type revealed decreases in satellite cells per myofiber in both MHC IIx (P Ͻ 0.05) and MHC IIb myofiber (P Ͻ 0.05) types (B).
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croscopy of individual myofiber types (50) . Our present study demonstrates the utility of a less complex multichannel IF technique coupled with DIC imaging for assessing myofiber type differences in protein expression (specifically myostatin and actRIIB) relative to the myofiber type-specific atrophy response observed following chronic unloading. This technique also allows myonuclei, satellite cells, and interstitial cells to be spatially resolved to assess their potential role in this response.
Myostatin was found almost exclusively associated with satellite cells, myonuclei, and interstitial nuclei. This finding was not expected, and we may be the first to histologically demonstrate myonuclear localization of myostatin in skeletal muscle cross sections. However, a previous fractionation study demonstrated myostatin to be exclusively found in the nuclear fraction of C2C12 myotubes (3) . The localization of myostatin in myonuclei and satellite cells may mean that specific behavior of myonuclei and satellite cells needs to be taken into consideration when defining the role of myostatin in unloading-induced muscle atrophy.
Effect of hindlimb suspension on myonuclei and satellite cell numbers. The number of myonuclei and satellite cells per myofiber was found to be less in HLS rats compared with AMBU controls. Further analysis revealed a myofiber typespecific response where myonuclei per myofiber decreased in MHC IIx myofibers only, where satellite cells per myofiber decreased in both MHC IIx and MHC IIb. Myonuclei per myofiber was also found to be higher in MHC IIb compared with all other myofiber types, independent of loading condition (Fig. 8) . The decrease found in myonuclei and satellite cells per myofiber with HLS is in agreement with some studies (2, 12, 36, 37, 42, 51) and in disagreement with others (7, 8, 25) . The discrepancy between these studies may be due to differences in cross-sectioning techniques (longitudinal vs. transverse), the muscles used (soleus, plantaris, and extensor digitorum longus), or even the regions of the myofiber being analyzed. For example, Wang et al. (51) found that in longitudinal cross sections the distal and proximal regions of the myofiber showed no change while the central regions of the myofiber decreased in myonuclei and satellite cell content due to rat hindlimb suspension.
Effect of hindlimb suspension on myostatin expression in myonuclei and satellite cells. Based on observations across species (i.e., human, bovine, and rodent) with regard to the role of myostatin in muscle physiology, there is no doubt that the absence of myostatin, either by a process of natural mutation, functional inhibition, or knockout, results in significant skeletal muscle hypertrophy (9, 19, 24, 31, 41, (53) (54) (55) . However, the role of increased myostatin expression in modulating muscle atrophy during chronic unloading is less clear. As myostatin is intimately linked to skeletal muscle size, we hypothesized that myostatin protein expression (quantified using IF staining) would be significantly greater in HLS muscle samples compared with ambulatory control muscle samples. Surprisingly, we detected a significant reduction in myostatin staining in myonuclei after 10 days of unloading, regardless of myofiber type. However, when the aggregate amounts of both myonuclei and satellite cell myostatin staining in the same muscle were taken into account in aggregate, no overall or myofiber typespecific differences were found in myostatin expression between control and experimental conditions (i.e., ambulatory or HLS).
Although these results were unexpected, others have also demonstrated a lack of change in myostatin expression between unloading conditions using alternate methods of quantification. Carlson et al. (10) found an increase in myostatin mRNA in the gastrocnemius and plantaris following the first day of HLS in mice, but no difference compared with controls following 3 and 7 days of HLS. Kawada et al. (26) showed no changes in myostatin protein in the gastrocnemius and plantaris of mice following 14 days HLS, while Jones et al. (22) showed no changes in myostatin mRNA following 10 days of cast immobilization in the human vastus lateralis muscle. However, these data and the data reported here are in contrast to observations reported by Wheling et al. (52) who demonstrated a 37 and 110% increase in myostatin protein and mRNA, respectively, coinciding with a 16% decrease in plantaris muscle mass following 10 days HLS in rats. One possible explanation for this dichotomy is that myostatin expression levels may Fig. 9 . Quantitative analysis of myostatin (A) and sarcoplasmic actRIIB (B) IF staining in the rat Red TA. Quantitative analysis of myostatin staining in myonuclei and satellite cells (expressed as total pixel intensity within the region of interest, i.e., Integrated Density) disclosed greater amounts of myostatin staining in the myonuclei of control (AMBU) compared with HLS animals (different from AMBU, *P Ͻ 0.05), while no difference in satellite cell staining was found between conditions (A). Quantitative analysis of sarcoplasmic actRIIB staining intensity (expressed as total pixel intensity normalized to area, i.e., Grayscale Intensity) was found to be significantly different between myofiber types (but not loading condition) with the following trend: I Ͻ IIa Ͻ IIx Ͻ IIb (linear polynomial contrast plot, **P Ͻ 0.01). No differences were found in actRIIB sarcolemma staining intensity relative to fiber type. change over time in chronically unloaded muscle and that myostatin expression may be transiently overexpressed during the early phases of unloading returning to normal levels after extended unloading. It is also possible that chronic unloading induced by HLS does not alter myostatin expression in the TA, as functionally the TA does not serve primarily as an antigravity muscle in the rat.
Although overall myostatin staining was similar between conditions, a loading effect was observed when myonuclei and satellite cells were analyzed separately in that AMBU rats had greater myonuclear staining compared with HLS rats, while satellite cell staining remained unchanged between conditions (Fig. 9A ). This suggests myonuclei and satellite cells behave differentially during chronic unloading and may play different roles in regulating skeletal muscle atrophy. It is difficult to speculate what these roles may be given there are no intermediate time points or other comparisons available in the literature. Future research should focus on the time course of changes in both myofiber CSA and myostatin expression in the TA relative to myofiber type, the role of satellite cells during muscle atrophy, as well as the effects of chronic unloading in antigravity and nonantigravity muscles.
Spatially resolving ActRIIB expression. While myostatin is recognized as a potent atrophic factor in skeletal muscle, its biological action on target cells is dependent on activation of its receptor, actRIIB. As such, actRIIB as well as its overall sarcolemma expression level is also a likely candidate involved in the regulation of muscle atrophy. Evidence to support this contention, which reveals significant differences in cytoplasmic staining of actRIIB between myofiber types in the following trend (I Ͻ IIa Ͻ IIx Ͻ IIb; Fig. 9B ), is presented here. Furthermore, myofiber types exhibiting the greatest sarcoplasmic actRIIB staining correspond to myofibers displaying the greatest atrophy in response to HLS, suggesting that differential myofiber type-specific actRIIB expression may be responsible for a myostatin-mediate, myofiber type-selective atrophy following chronic unloading. Although there were no differences observed between myofiber types with regard to actRIIB membrane staining, it is also possible that the rate of actRIIB translocation and/or subsequent sarcolemma turnover is lower in type IIx and type IIb myofibers, thereby accounting for an increase in accumulation of actRIIB within the sarcoplasm of these myofiber types.
Hindlimb suspension on ActRIIB expression. Despite the differential cytoplasmic staining of actRIIB observed between myofiber types, no difference was found in actRIIB expression between loading conditions. Jones et al. (22) also showed no change in actRIIB protein expression in human vastus lateralis following cast immobilization nor any change following reloading, while Allen et al. (1) demonstrated a decrease in actRIIB mRNA in the gastrocnemius of space flown rats but no change following HLS. The time course of actRIIB expression during chronic unloading has not yet been investigated and may have similar time course patterns of expression as myostatin. Regardless, baseline differences in actRIIB expression between myofiber types suggest a greater sensitivity of these myofibers (i.e., type IIx and type IIb myofibers) to the effects of myostatin. As such, when myostatin expression increases at the onset of chronic unloading, logically these fiber types will be affected the most by increased levels of myostatin and therefore undergo the greatest degree of atrophy. As such, selective myofiber type actRIIB expression can explain the myofiber-selective atrophy response observed during chromic unloading of skeletal muscle.
Myostatin and ActRIIB expression in interstitial cells. One unexpected finding was the presence of myostatin and actRIIB staining in interstitial cells, satellite cells and myonuclei. While it is possible that some myonuclei that were considered interstitial may have in fact been satellite cells whose attachment to their membrane was severed in the cross-sectioning process (Fig. 4) , nuclei depicted in Fig. 10 are unmistakably independent of any particular fiber type. There are a number of distinct progenitor cells in the interstitial space of muscle capable of multiple lines of differentiation (18, 47) . Tamaki et al. (47) identified cell structures very similar to what is seen in Fig. 10 , D-F, as either myogenic, hematopoetic, or endothelial progenitor cells. Dupont-Versteegden et al. (14) illustrated interstitial nuclei staining positive for markers of apoptosis that histolog- ically are very similar to those identified in Fig. 10 , A-F. Although it is not possible to definitively claim that the interstitial cells identified in our images are the same type of cells previously reported, it is likely that at least some of these cells previously identified by other researchers as interstitial nuclei/cells would also have expression myostatin and actRIIB as observed in our present study (Fig. 10 ). As such, our observations suggest that interstitial cells are likely to be active participants in skeletal muscle remodeling process. Myostatin staining appears to be present in all myonuclei and interstitial cell types, while actRIIB appears in some interstitial cells as depicted in Fig. 10 . Tamaki et al. (47) also demonstrated that the 49% of interstitial cells express myogenic-specific markers and concomitantly express MyoD protein and mRNA, and pax7 and pax3, whereas hematopoetic and endothelial progenitors did not. This could potentially explain why actRIIB is differentially expressed in these different cell types Fig. 10 , D-F; one interstitial cell may be a myogenic progenitor while the other two are not.
Myostatin expression in adipocytes. One unresolved question raised by our experimental results is the relative importance of myostatin derived from skeletal muscle tissue compared with other sources within the body. Since myostatin is also produced by adipocytes, it is entirely possible that circulating myostatin released from adipocytes during HLS, rather than skeletal muscle tissue, could potentially be responsible for the myofiber atrophy observed during unloading. While speculative, it is interesting to note that in the gastrocnemius, a muscle predominately comprised of type II myofibers, chronically obese rodents also exhibit myofiber atrophy compared with lean controls (27, 44) . However, it is unclear if obesity per se impacts the circulating levels of myostatin, although it is interesting to speculate that adipose tissue-derived myostatin may play a much more significant role in the reduced skeletal muscle mass observed in physical inactivity-related obesity than previously thought.
Summary. In summary, our results demonstrate significant differences in sarcoplasmic actRIIB protein expression which in turn is correlated with a myofiber type and myofiberselective atrophy induced by HLS. Our data suggest that the myofiber type-selective atrophy detected following HLS/ chronic unloading is related to the action of myostatin mediated through differential expression of the myostatin receptor actRIIB by myofibers. Our data also show myofiber typespecific decreases in myocnuclei and satellite cells per myofiber and the presence of myostatin and actRIIB protein in interstitial cells, whose role in skeletal muscle remodeling has yet to be fully determined. In addition, we have developed a unique methodology that can serve as a valuable tool in furthering our understanding of the effects of not only chronic unloading but a range of other physiological and pathological conditions on myofiber type-specific protein expression and myofiber type-selective adaptations. 
